IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses

Nature Communications

Volumn 7, Issue , 2016, Pages

  Lee, Chang Min ^a   He, Chuan Hua ^a   Nour, Adel M ^a   Zhou, Yang ^a   Ma, Bing ^a   Park, Jin Wook ^a   Kim, Kyung Hee ^b   Cruz, Charles Dela ^c   Sharma, Lokesh ^c   Nasr, Mahmoud L ^d   Modis, Yorgo ^e   Lee, Chun Geun ^a   Elias, Jack A ^a,f  

^a BROWN UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITINASE; CHITINASE 3 LIKE 1; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 13 RECEPTOR ALPHA2; MEMBRANE PROTEIN; SMALL INTERFERING RNA; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSMEMBRANE PROTEIN 219; UNCLASSIFIED DRUG; CHI3L1 PROTEIN, HUMAN; CHITINASE 3 LIKE PROTEIN 1; PROTEIN KINASE B; TGFB1 PROTEIN, MOUSE;

APOPTOSIS; BIOASSAY; CANCER; CHEMICAL BINDING; ENZYME ACTIVITY; GENETIC ANALYSIS; INHIBITION; PROTEIN; YEAST;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; LUNG INJURY; MELANOMA METASTASIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE REACTION; ANIMAL; C57BL MOUSE; EXPERIMENTAL MELANOMA; LUNG TUMOR; MAPK SIGNALING; METABOLISM; METASTASIS; PATHOLOGY; SECONDARY; TUMOR CELL LINE; TWO HYBRID SYSTEM; WNT SIGNALING;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CHITINASE-3-LIKE PROTEIN 1; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; LUNG INJURY; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MELANOMA, EXPERIMENTAL; MICE, INBRED C57BL; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFORMING GROWTH FACTOR BETA1; TWO-HYBRID SYSTEM TECHNIQUES; WNT SIGNALING PATHWAY;

EID: 84987806957     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12752     Document Type: Article

References (40)

1. Lupardus, P. J., Birnbaum, M. E., Garcia, K. C. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure 18, 332-342 (2010).
2. Strober, W., Kitani, A., Fichtner-Feigl, S., Fuss, I. J. The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillance. Curr. Mol. Med. 9, 740-750 (2009).
3. Konstantinidis, A. K. et al. Cellular localizataion of interleukin 13 receptor alpha2 in human primary bronchial epithelial cells and fibroblasts. J. Investig. Allergol. Clin. Immunol. 18, 174-180 (2008).
4. Chiaramonte, M. G. et al. Regulation and function of the interleukin 13 receptor alpha2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197, 687-701 (2003).
5. Wood, N. et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J. Exp. Med. 197, 703-709 (2003).
6. Daines, M. O. et al. Level of expression of IL-13Ralpha2 impacts receptor distribution and IL-13 signaling. J. Immunol. 176, 7495-7501 (2006).
7. Fichtner-Feigl, S. et al. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J. Immunol. 178, 5859-5870 (2007).
8. Fichtner-Feigl, S., Strober, S., Kawakami, K., Puri, R. K., Kitani, A. IL-13 signaling through the IL-13alpha(2) receptor is involved in induction of TGF-beta(1) production and fibrosis. Nat. Med. 12, 99-106 (2006).
9. Fichtner-Feigl, S., Strober, W., Geissler, E. K., Schlitt, H.-J. Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunol. 1, S24-S27 (2008).
10. Fichtner-Feigl, S. et al. Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2. Cancer Res. 68, 3467-3475 (2008).
11. Yang, J. S., Allahverdian, S., Singhera, G. K., MacRedmond, R. E., Dorscheid, D. R. IL-13Ralpha2/AP-1 complex signalling mediates airway epithelial repair without effects on remodeling pathways. Allergy Asthma Clin. Immunol. 6, 27-28 (2010).
12. Yang, J. S. Y., Wadsworth, S. J., Singhera, G. K., Dorscheid, D. The regulation of IL-13ralpha1 and IL-13ralpha2 expression and distribution in airway epithelial repair. Am. J. Respir. Crit. Care Med. 183, A2812 (2011).
13. He, C. H. et al. Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor alpha2. Cell Rep. 4, 830-841 (2013).
14. Grove, T. Z., Hands, M., Regan, L. Creating novel proteins by combining design and selection. Protein Eng. Des. Sel. 23, 449-455 (2010).
15. Bhandari, V. et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat. Med. 12, 1286-1293 (2006).
16. Sohn, M. H. et al. The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury. Am. J. Respir. Crit. Care Med. 182, 918-928 (2010).
17. Tabata, Y., Khurana Hershey, G. K. IL-13 receptor isoforms: breaking through the complexity. Curr. Allergy Asthma Rep. 7, 338-345 (2007).
18. Zheng, T. et al. IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung. J. Immunol. 180, 522-529 (2008).
19. Walford, H. H., Doherty, T. A. STAT6 and lung inflammation. JAKSTAT 2, e25301 (2013).
20. Abraham, R. T., Weiss, A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4, 301-308 (2004).
21. Smith-Garvin, J. E., Koretzky, G. A., Jordan, M. S. T cell activation. Annu. Rev. Immunol. 27, 591-619 (2009).
22. Lee, C. G. et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J. Exp. Med. 206, 1149-1166 (2009).
23. Dela Cruz, C. S. et al. Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe 12, 34-46 (2012).
24. Ma, B. et al. Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis. Cancer Res. 75, 487-496 (2014).
25. Ingermann, A. R. et al. Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J. Biol. Chem. 285, 30233-30246 (2010).
26. Baxter, R. C. Insulin-like growth factor binding protein-3 (IGFBP-3): novel ligands mediate unexpected functions. J. Cell Commun. Signal 7, 179-189 (2013).
27. Kielczewski, J. L. et al. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ. Res. 105, 897-905 (2009).
28. Lofqvist, C. et al. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc. Natl Acad. Sci. USA 104, 10589-10594 (2007).
29. Martin, J. L., Jambazov, S. Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase. Endocrinology 147, 4400-4409 (2006).
30. Oh, Y., Muller, H. L., Lamson, G., Rosenfeld, R. G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J. Biol. Chem. 268, 14964-14971 (1993).
31. Shao, R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front. Physiol. 4, 122 (2013).
32. Kaviratne, M. et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J. Immunol. 173, 4020-4029 (2004).
33. Lee, C. G. et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194, 809-821 (2001).
34. Fichtner-Feigl, S. et al. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J. Immunol. 178, 5859-5870 (2007).
35. Ritchie, T. K. et al. Reconstitution of membrane proteins in phospholipid bilayer nanodiscs. Methods Enzymol. 464, 211-231 (2009).
36. Quick, M., Javitch, J. A. Monitoring the function of membrane transport proteins in detergent-solubilized form. Proc. Natl Acad. Sci. USA 104, 3603-3608 (2007).
37. Chou, J. J., Kaufman, J. D., Stahl, S. J., Wingfield, P. T., Bax, A. Micelle-induced curvature in a water-insoluble HIV-1 Env peptide revealed by NMR dipolar coupling measurement in stretched polyacrylamide gel. J. Am. Chem. Soc. 124, 2450-2451 (2002).
38. Garavito, R. M., Ferguson-Miller, S. Detergents as tools in membrane biochemistry. J. Biol. Chem. 276, 32403-32406 (2001).
39. Harder, D., Fotiadis, D. Measuring substrate binding and affinity of purified membrane transport proteins using the scintillation proximity assay. Nat. Protoc. 7, 1569-1578 (2012).
40. Inglese, J., Blatchly, R. A., Benkovic, S. J. A multisubstrate adduct inhibitor of a purine biosynthetic enzyme with a picomolar dissociation constant. J. Med. Chem. 32, 937-940 (1989).